Legal Representation
Attorney
SCOTT D. WOLDOW
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 24, 2024 | MAB3 | E | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | Loading... |
| Jul 22, 2024 | EXPT | T | EXPARTE APPEAL TERMINATED | Loading... |
| Jul 21, 2024 | ABN3 | O | ABANDONMENT - AFTER EX PARTE APPEAL | Loading... |
| Jun 12, 2024 | EXFB | T | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF | Loading... |
| Apr 1, 2024 | GECD | O | ACTION DENYING REQ FOR RECON E-MAILED | Loading... |
| Apr 1, 2024 | GEA1 | O | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | Loading... |
| Apr 1, 2024 | CNCF | W | SU - ACTION CONTINUING FINAL - WRITTEN | Loading... |
| Mar 7, 2024 | EXPI | T | EX PARTE APPEAL-INSTITUTED | Loading... |
| Mar 7, 2024 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
| Mar 7, 2024 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | Loading... |
| Feb 14, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 14, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 14, 2024 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Dec 7, 2023 | CNFR | W | SU - FINAL REFUSAL - WRITTEN | Loading... |
| Dec 7, 2023 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Dec 7, 2023 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Oct 25, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 25, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 25, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 14, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 14, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 14, 2023 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Jul 17, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 17, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 17, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 17, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 17, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 17, 2023 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Mar 8, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Mar 3, 2023 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Mar 3, 2023 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Aug 20, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 19, 2022 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Aug 19, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Aug 10, 2022 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Aug 10, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 12, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 10, 2022 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Feb 10, 2022 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Feb 10, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 12, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 10, 2021 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Aug 10, 2021 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Aug 10, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 12, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 10, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Feb 10, 2021 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Feb 10, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 12, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 10, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Detailed Classifications
Class 035
Healthcare education services, namely, promoting awareness of immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals to patients, caregivers and/or healthcare professionals
First Use Anywhere:
20220000
First Use in Commerce:
20220000
Class 044
Healthcare and healthcare information services, namely, providing information concerning immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals
First Use Anywhere:
20220000
First Use in Commerce:
20220000
Additional Information
Pseudo Mark
THINK INTRAVENOUS IMMUNOGLOBULIN
Classification
International Classes
035
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"IVIG"